RR

Active Director Director DIN 10378837
DIN 10378837 First appointment Nov 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Raja Ram

Data last updated:

Raja Ram is a Director at Sycus Lifesciences Private Limited (since 2023). The company operates in Paper. Sycus Lifesciences Private Limited reported revenue of ₹2.21 Cr (FY 2025).

DIN 10378837
Primary Designation Director
Industry Paper
First Appointment 04 Nov 2023
Oldest Company Age 3 yrs
Largest company Sycus Lifesciences Private Limited · ₹2.21 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sycus Lifesciences Private Limited U21009MP2023PTC066333
Director04 Nov 20232023₹2.21 Cr (FY 2025)Active

Board colleagues of Raja Ram

Directorship timeline

Open interactive timeline →
Sycus Lifesciences Private Limited
Premium access

Shareholding and investment profile for Raja Ram

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raja Ram

Raja Ram currently holds 1 directorship: Sycus Lifesciences Private Limited (Director, since 04 Nov 2023, revenue ₹2.21 Cr (FY 2025)).

Raja Ram was first appointed on 04 Nov 2023 as Director at Sycus Lifesciences Private Limited.

The current boards of Raja Ram's companies include Krishnakant Lakher (Sycus Lifesciences Private Limited), Pankaj Kumar Soni (Sycus Lifesciences Private Limited), Vinit Pandey (Sycus Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available